I'm very disappointed with the way things are being managed in this "supposed" public company. It is getting worse as time moves on.
I invested into CDY principally for their midkine science to come into use in the commercial space. I had no problem with the acquisition of Advangen and subsequent rolling out of Evolis - although (for the umpteenth time) - I think going to the US market was a "cash sucking" error...and still do!
This latest unplanned and spontaneous "out of the box" foray into the Covid-19 space has been promoted as being "positively opportunistic". But I think it is evidence of how the running of the company is becoming more and more cavalier (to be nice!) - almost like we are in the middle of the "wild, wild west". based on the comments I read on here (if true) - the company is turning into a bloody circus.
I can't understand why Maria involved a firm like Mr Silver's Evolution Capital - when there must be better reputational broking firms around?
Hawk's comments like - " It appears the CEO has cleaned him up big time" and, "trying to out compete and out position one another" and, "slippery Stephen has definitely met his match with the CEO of CDY" seems to suggest there is some sort of personal power play going on.
What a shamozzle.
- Forums
- ASX - By Stock
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
I'm very disappointed with the way things are being managed in...
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online